FULC
Fulcrum Therapeutics Inc
NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY
$7.15
-3.90% today
Updated 2026-04-29
Market cap
$522.15M
P/E ratio
—
P/S ratio
2.66x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$4 – $16
Volume
1.2M
Fulcrum Therapeutics Inc (FULC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $750000.00 | $8.82M | $19.16M | $6.34M | $2.81M | $80.00M | $0.00 |
| Revenue growth (YoY) | — | — | — | +1076.4% | +117.2% | -66.9% | -55.8% | +2752.0% | -100.0% |
| Cost of revenue | $715000.00 | $1.34M | $2.05M | $2.38M | $2.52M | $76.78M | $71.80M | $63.39M | $1.39M |
| Gross profit | $-715000.00 | $-1.34M | $-2.05M | $8.82M | $19.16M | $-70.44M | $2.81M | $16.61M | $-1.39M |
| Gross margin | — | — | -273.7% | 100.0% | 100.0% | -1110.7% | 100.0% | 20.8% | — |
| R&D | $18.49M | $25.18M | $71.07M | $59.04M | $69.70M | $76.78M | $71.80M | $63.39M | $56.10M |
| SG&A | $4.50M | $8.31M | $13.14M | $21.39M | $30.52M | $41.69M | $41.67M | $34.97M | $28.67M |
| Operating income | $-22.99M | $-33.50M | $-84.22M | $-71.61M | $-81.05M | $-112.56M | $-110.66M | $-21.90M | $-84.77M |
| Operating margin | — | — | -11228.9% | -811.6% | -423.0% | -1774.9% | -3945.2% | -27.4% | — |
| EBITDA | $-22.28M | $-32.15M | $-82.16M | $-69.23M | $-78.54M | $-109.72M | $-108.49M | $-18.24M | $-73.49M |
| EBITDA margin | — | — | -10955.2% | -784.7% | -409.8% | -1730.1% | -3867.8% | -22.8% | — |
| EBIT | $-22.99M | $-33.50M | $-84.22M | $-71.61M | $-81.05M | $-112.13M | $-110.66M | $-19.83M | $-74.88M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $2.72M | $2.69M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-22.96M | $-32.59M | $-79.11M | $-68.44M | $-78.33M | $-109.87M | $-97.33M | $-9.72M | $-74.88M |
| Net income growth (YoY) | — | -41.9% | -142.8% | +13.5% | -14.5% | -40.3% | +11.4% | +90.0% | -670.0% |
| Profit margin | — | — | -10548.4% | -775.7% | -408.8% | -1732.4% | -3470.1% | -12.2% | — |